Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S.

For a century, we’ve fought friction with horsepower. New "biomimetic" research suggests that to break the efficiency wall, ...

Recurring revenues grew 9%; up 8% constant currency Diluted EPS was $2.42 and Adjusted EPS rose 2% to $1.59 Raising outlook for FY'26 Adjusted EPS growth to 9-12% Reaffirming ...

Chain Bridge Bancorp, Inc. (NYSE: CBNA) (the "Company"), the holding company for Chain Bridge Bank, N.A. (the "Bank"), today announced financial results for the fourth quarter of 2025 and the twelve ...

Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding Ja ...